Reduction in healthcare and societal resource utilization associated with cladribine tablets in patients with relapsing-remitting multiple sclerosis: analysis of economic data from the CLARITY Study.
Ali S, Paracha N, Cook S, Giovannoni G, Comi G, Rammohan K, Rieckmann P, Sørensen P S, Vermersch P, Greenberg S, et al.
Clin Drug Investig. 2012 Jan 1; 32(1):15-27. PMID: 22017519.Abstract